The C.A.M. Report
Complementary and Alternative Medicine: Fair, Balanced, and to the Point
  • About this web log

    This blog ran from 2006 to 2016 and was intended as an objective and dispassionate source of information on the latest CAM research. Since my background is in pharmacy and allopathic medicine, I view all CAM as advancing through the development pipeline to eventually become integrated into mainstream medical practice. Some will succeed while others fail. But all are treated fairly here.

  • About the author

    John Russo, Jr., PharmD, is president of The MedCom Resource, Inc. Previously, he was senior vice president of medical communications at, a complementary and alternative medicine website.

  • Common sense considerations

    The material on this weblog is for informational purposes. It is not medical advice or counsel. Be smart, consult your health professional before using CAM.

  • Recent Posts

  • Recent Comments

    Pomegranate juice doesn’t inhibit cytochrome P450 enzymes in humans

    Several years ago a study in human liver tissue and in rats concluded that pomegranate juice inhibited CYP3A — a liver enzyme in the cytochrome P450 system important for metabolizing drugs. The implications were that — just as with grapefruit — people taking drugs such as statins for cholesterol might be exposed to much higher blood levels and greater risk of side effects.

    We now find that when studied in healthy volunteers, pomegranate juice is not associated with this risk.

    • In 13 volunteer, drinking 8 ounces of pomegranate juice had no effect on the blood levels of midazolam (Versed) — a benzodiazepine type drug used as a sedative that is sensitive to this enzyme interaction.
    • Drinking grapefruit juice did increase the blood levels of midazolam

    Some men drink pomegranate juice to slow the rise in prostate-specific antigen levels (PSA).

    Other drugs affected by grapefruit juice are listed here.

    2/26/07 10:20 JR

    Leave a Comment

    You must be logged in to post a comment.